Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
12.11
+0.05 (0.41%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $404.51 million as of April 28, 2025. Its market cap has increased by 229.41% in one year.
Market Cap
404.51M
Enterprise Value
352.32M
1-Year Change
229.41%
Ranking
Category
Stock Price
$12.11
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $404.51M, an increase of 14,881.93%. That is a compound annual growth rate of 105.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 404.50M | 5.06% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |